Organon Co Stock Analysis

Organon Stock Analysis Notes

About 84.0% of the company shares are owned by institutional investors. The company last dividend was issued on the 24th of February 2025. Organon Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Organon Co. was incorporated in 2020 and is based in Jersey City, New Jersey. Organon CO operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 9300 people. To find out more about Organon Co contact Kevin Ali at (551) 430-6900 or learn more at https://www.organon.com.

Organon Investment Alerts

Organon Upcoming and Recent Events

Organon Market Capitalization

The company currently falls under 'Mid-Cap' category with a total capitalization of 4.05 B.

Organon Profitablity

The company has Net Profit Margin of 0.13 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.19 %, which entails that for every 100 dollars of revenue, it generated $0.19 of operating income.

Technical Drivers

As of the 20th of March, Organon holds the Semi Deviation of 2.38, coefficient of variation of 1372.95, and Risk Adjusted Performance of 0.0714. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Organon, as well as the relationship between them.

Organon Price Movement Analysis

Organon Insider Trading Activities

Organon Outstanding Bonds

Organon Predictive Daily Indicators

Organon Forecast Models

Organon's time-series forecasting models are one of many Organon's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Organon's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Organon prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Organon shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Organon. By using and applying Organon Stock analysis, traders can create a robust methodology for identifying Organon entry and exit points for their positions.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Organon Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organon. If investors know Organon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organon listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Organon is measured differently than its book value, which is the value of Organon that is recorded on the company's balance sheet. Investors also form their own opinion of Organon's value that differs from its market value or its book value, called intrinsic value, which is Organon's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organon's market value can be influenced by many factors that don't directly affect Organon's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Organon's value and its price as these two are different measures arrived at by different means. Investors typically determine if Organon is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organon's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.